Clinical need for continuous glucose monitoring in the hospital

Journal of Diabetes Science and Technology

Volumn 3, Issue 6, 2009, Pages 1309-1318

  Joseph, Jeffrey I ^a   Hipszer, Brian ^a   Mraovic, Boris ^a   Chervoneva, Inna ^a   Joseph, Mark ^a   Grunwald, Zvi ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Continuous glucose monitor; Diabetes; Glucose sensor; Hospital

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN;

AUTOMATION; BLOOD; BLOOD GLUCOSE MONITORING; DRUG EFFECT; EQUIPMENT; EQUIPMENT DESIGN; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSTRUMENTATION; INSULIN INFUSION; METABOLISM; PREDICTION AND FORECASTING; REVIEW; STANDARD; TIME;

AUTOMATION; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIAGNOSTIC EQUIPMENT; EQUIPMENT DESIGN; GLUCOSE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; INSULIN INFUSION SYSTEMS; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 77956165412     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300611     Document Type: Conference Paper

References (121)

1. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471-8. (Pubitemid 37475630)
2. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35(10):2262-7. (Pubitemid 47476221)
3. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553-91. (Pubitemid 38174086)
4. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill? Diabetologia. 2006;49(8):1722-5. (Pubitemid 44025024)
5. Braithwaite SS, Buie MM, Thompson CL, Baldwin DF, Oertel MD, Robertson BA, Mehrotra HP. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract. 2004;10 Suppl 2:89-99.
6. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med. 1986;315(20):1245-50. (Pubitemid 17049682)
7. Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care. 2007;30(2):367-9. (Pubitemid 46198347)
8. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
9. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15(4):370-7. (Pubitemid 44859176)
10. Joseph JI. Management of the diabetic surgical patient. In: Textbook of type 2 diabetes. Martin Dunitz; 2007.
11. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903-11. (Pubitemid 44664648)
12. Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care. 2007;30(4):1005-11. (Pubitemid 46556604)
13. Lipshutz AK, Gropper MA. Perioperative glycemic control: an evidence-based review. Anesthesiology. 2009;110(2):408-21.
14. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10 Suppl 2:71-80.
15. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006;12(4):458-68.
16. Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77-82.
17. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353-69.
18. Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA, Dziura JD, Inzucchi SE. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004;6(3):339-47. (Pubitemid 38821619)
19. Vriesendorp TM, DeVries JH, Holleman F, Dzoljic M, Hoekstra JB. The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther. 2005;7(2):315-22. (Pubitemid 40586376)
20. Ganesh A, Hipszer B, Loomba N, Torjman MC, Joseph J. Evaluation of the VIA blood chemistry monitor for glucose in healthy and diabetic volunteers. J Diabetes Sci Technol. 2008;2(2):182,182-93.
21. Hipszer B, Furlong KJ, Lessin JB, Grunwald Z, Joseph JI. Continuous glucose monitoring in the perioperative period. Anesthesiology. 2006;105:A583.
22. Hipszer B, Chervoneva I, Gratch DM, Heitz JW, Maguire DP, Yeo CJ, Grunwald Z, Joseph JI. The performance of subcutaneous glucose sensors in surgical patients. J Diabetes Sci Technol. 2008;2(2):A71.
23. De Block C, Manuel-Y-Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006;29(8):1750-6. (Pubitemid 44156625)
24. Murakami A, Gutierrez MA, Lage SH, Rebelo MF, Guiraldelli RH, Ramires JA. A continuous glucose monitoring system in critical cardiac patients in the intensive care unit. Comput Cardiol. 2006:233-6.
25. Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, Meertens JH, Zijlstra JG. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care. 2006;10(5):R135.
26. Bochicchio GV, Bochicchio KM, Lettich K, Lambert P, Herrera A, Lumpkins K, Scalea T, Magarian P. Cutting edge technology in tight glycemic control (TGC). Crit Care Med. 2007;35 Suppl:A142.
27. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care. 2002;25(5):889-93. (Pubitemid 41094288)
28. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G. Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab. 2000;278(4):E716-28. (Pubitemid 30215184)
29. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed. 2003;7(1):43-53.
30. Widness JA, Kulhavy JC, Johnson KJ, Cress GA, Kromer IJ, Acarregui MJ, Feld RD. Clinical performance of an in-line point-of-care monitor in neonates. Pediatrics. 2000;106(3):497-504. (Pubitemid 30664135)
31. Garg SK. The future of continuous glucose monitoring. Diabetes Technol Ther. 2009;11 Suppl 1:S1-3.
32. McGarraugh G. The chemistry of commercial continuous glucose monitors. Diabetes Technol Ther. 2009;11 Suppl 1:S17-24.
33. Joseph JI, Goldstein BJ. New devices and drugs on the horizon. In: Goldstein BJ, Muller-Wieland D, editors. Textbook of type 2 diabetes. Informa Healthcare; 2003. p. 447-56.
34. Rossetti P, Porcellati F, Fanelli CG, Bolli GB. Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. Diabetes Technol Ther. 2006;8(3):326-37. (Pubitemid 46100527)
35. Allen HF, Rake A, Roy M, Brenner D, McKiernan CA. Prospective detection of hyperglycemia in critically ill children using continuous glucose monitoring. Pediatr Crit Care Med. 2008;9(2):153-8. (Pubitemid 351355024)
36. Reach G. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther. 2008;10(2):69-80. (Pubitemid 351230288)
37. Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11 Suppl 1:S55-67.
38. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense freestyle navigator data. Diabetes Care. 2004;27(8):1922-8. (Pubitemid 38989233)
39. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181-6. (Pubitemid 47359011)
40. Torjman MC, Dalal N, Goldberg ME. Glucose monitoring in acute care: technologies on the horizon. J Diabetes Sci Technol. 2008;2(2):178-81.
41. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359-66. (Pubitemid 36232926)
42. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61. (Pubitemid 43200296)
43. Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R, Pieber TR. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients: response to Ligtenberg et al. Diabetes Care. 2006;29(8):1987-8. (Pubitemid 44156675)
44. Chee F, Fernando T, van Heerden PV. Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care. 2002;30(3):295-307.
45. Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Lotz T, Wake GC, Broughton B.Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol Ther. 2005;7(2):274-82. (Pubitemid 40586371)
46. Galletti PM, Kuntschen FR, Hahn C. Experimental and clinical studies with servo-controlled glucose and insulin administration during cardiopulmonary bypass. Mt Sinai J Med. 1985;52(7):500-7. (Pubitemid 16237839)
47. Schwartz SS, Horwitz DL, Zehfus B, Langer B, Moossa AR, Ribeiro G, Kaplan E, Rubenstein AH. Use of a glucose controlled insulin infusion system (artificial beta cell) to control diabetes during surgery. Diabetologia. 1979;16(3):157-64. (Pubitemid 9200514)
48. Steed RD, Davidson PC, Bode BW, Sivitz WI. Computer-controlled intravenous insulin infusion using intermittent bedside glucose monitoring: one year's experience. Diabetes. 1986;35 Suppl. 1:32A.
49. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005;28(10):2418-23. (Pubitemid 41384287)
50. Dunn K, Miller E, Cochran S, Burgess W. Optimized glucose management with EndoTool intravenous insulin (IVI) dosing. Diabetes. 2007:0463-P.
51. Schaller R, Feichtner F, Kohler H, Bodenlenz M, Plank J, Wutte A, Mader JK, Ellmerer M, Hellmich R, Wedig H, Hainisch R, Pieber TR, Schaupp L. A novel automated discontinuous venous blood monitoring system for ex vivo glucose determination in humans. Biosens Bioelectron. 2009;24(7):2239-45.
52. Kadish AH. A servomechanism for blood sugar control. Biomed Sci Instrum. 1963;1:171-6.
53. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W. An artificial endocrine pancreas. Diabetes. 1974;23(5):389-96.
54. Okabayashi T, Hnazaki K, Nishimori I, Sugimoto T, Maeda H, Yatabe T, Dabanaka K, Kobayashi M, Yamashita K. Continuous postoperative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci. 2008;53(5):1405-10. (Pubitemid 351514618)
55. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg. 2008;106(1):160-3, table of contents.
56. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand. 2009;53(1):66-71.
57. Ozyol MB, Herfarth C, Kerner W, Pfeiffer EF. Postoperative blood-sugar regulation in pancreatectomized patients using the artificial "beta cell". Chirurg. 1979;50(4):227-32. (Pubitemid 10226848)
58. Gin H, Catargi B, Rigalleau V, Rullier E, Roger P, Tabarin A. Experience with the Biostator for diagnosis and assisted surgery of 21 insulinomas. Eur J Endocrinol. 1998;139(4):371-7. (Pubitemid 28494080)
59. Lucisano JY, Edelman SV, Quinto BD, Wong DK. Development of a biosensor-based, patient-attached blood glucose monitoring system. Proc Am Chem Soc. 1997;76:256.
60. VIA blood chemistry monitor for glucose VIA V-GLU 1 operator's manual. San Diego, CA: VIA Medical Corporation; 1998.
61. Krinsley J, Zheng P, Hall D, Magarian P. ICU validation of the Optiscanner, a continuous glucose monitoring device. Crit Care Med. 2006;34(12):A67. Available from: http://journals.lww.com/ccmjournal/Fulltext/ 2006/12002/Icu-Validation-of-the-Optiscanner,-A-Continuous.236.aspx.
62. Plank J, Schaller R, Ellmerer M, Koller D, Eberhardt R, Kohler G, Shoemaker M, Obermaier K, Toller W, Pieber T, Schaupp L. Continuous glucose monitoring using the SCGM1 system in postcardiothoracic surgery patients. Crit Care. 2006;10(Suppl 1):P254. Available from: http://ccforum.com/supplements/10/ S1.
63. Heise HM, Kondepati VR, Damm U, Licht M, Feichtner F, Mader JM, Ellmerer M. Microdialysis based monitoring of subcutaneous interstitial and venous blood glucose in type 1 diabetic subjects by mid-infrared spectrometry for intensive insulin therapy. Optical Diagnostics Sensing VIII. January 2008.
64. Heise HM, Damm U, Bodenlenz M, Kondepati VR, Kohler G, Ellmerer M. Bedside monitoring of subcutaneous interstitial glucose in healthy individuals using microdialysis and infrared spectrometry. J Biomed Opt. 2007;12(2):024004.
65. Chuang H, Trieu M, Hurley J, Taylor EJ, England MR, Nasraway, Stanley A Jr. Pilot studies of transdermal continuous glucose measurement in outpatient diabetic patients and in patients during and after cardiac surgery. J Diabetes Sci Technol. 2008 2008;2(4):595-602.
66. Brauker J. Continuous glucose sensing: future technology developments. Diabetes Technol Ther. 2009;11 Suppl 1:S25-36.
67. Joseph J, Torjman MC. Implantable glucose sensors. In: Encyclopedia of Biomaterials. Marcel-Dekker Publisher; 2004.
68. Klonoff D, Bernhardt P, Ginsberg BH, Joseph JI, Mastrototaro JJ, Parker DR, Vesper H, Vigersky R. Performance metrics for continuous interstitial glucose monitoring; approved guideline. CSLI. 2008;28(33).
69. Rebrin K, Steil GM. Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol Ther. 2000;2(3):461-72.
70. Hipszer B, Joseph JI. Lag associated with interstitial glucose sensors used in a diabetic surgical patient. Anesthesiology. 2006 2006;105:A584.
71. Simon B, Treat V, Marco C, Rosenberg D, Joseph J, Hipszer B, Li Y, Chervoneva I, Padron-Massara L, Jabbour S. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS. Int J Clin Pract. 2008;62(12):1858-63.
72. Lodwig V, Heinemann L; Glucose Monitoring Study Group. Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technol Ther. 2003;5(4):572-86.
73. McGarraugh G, Bergenstal R. Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle navigator continuous glucose monitoring system. Diabetes Technol Ther. 2009;11(3):145-50.
74. Ward WK, Casey HM, Quinn MJ, Federiuk IF, Wood MD. A fully implantable subcutaneous glucose sensor array: enhanced accuracy from multiple sensing units and a median-based algorithm. Diabetes Technol Ther. 2003;5(6):943-52. (Pubitemid 38009932)
75. Piper HG, Alexander JL, Shukla A, Pigula F, Costello JM, Laussen PC, Jaksic T, Agus MS. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics. 2006;118(3):1176-84. (Pubitemid 46090061)
76. Logtenberg SJ, Kleefstra N, Snellen FT, Groenier KH, Slingerland RJ, Nierich AP, Bilo HJ. Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabetes Technol Ther. 2009;11(1):31-7.
77. Bailey PL, McJames SW, Cluff ML, Wells DT, Orr JA, Westenskow DR, Kern SE. Evaluation in volunteers of the VIA V-ABG automated bedside blood gas, chemistry, and hematocrit monitor. J Clin Monit Comput. 1998;14(5):339-46.
78. Kunjan K, Lloyd FP Jr. Automated blood sampling and glucose sensing in critical care settings. J Diabetes Sci Technol. 2008;2(2):194-200.
79. Kovatchev B, Anderson S, Heinemann L, Clarke W. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care. 2008;31(6):1160-4.
80. Sacks DB, Bernhardt P, Dunka LJ, Goldstein DE, Hortin GL, Mueller P. Point-of-care blood glucose testing in acute and chronic care facilities; approved guideline. NCCLS. 2002;22(17).
81. Desachy A, Vuagnat AC, Ghazali AD, Baudin OT, Longuet OH, Calvat SN, Gissot V. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc. 2008;83(4):400-5. (Pubitemid 351536465)
82. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778-85. (Pubitemid 41816412)
83. Fahy BG, Coursin DB. Critical glucose control: the devil is in the details. Mayo Clin Proc. 2008;83(4):394-7. (Pubitemid 351536463)
84. Finkielman JD, Oyen LJ, Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest. 2005;127(5):1749-51. (Pubitemid 46218804)
85. Soo Hoo GW. Tight blood glucose control in the ICU: how best to measure glucose control? Chest. 2008;133(1):316-7; author reply 317.
86. Nichols JH. What is accuracy and how close must the agreement be? Diabetes Technol Ther. 2005;7(3):558-62. (Pubitemid 40847820)
87. Sylvain HF, Pokorny ME, English SM, Benson NH, Whitley TW, Ferenczy CJ, Harrison JG. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care. 1995;4(1):44-8.
88. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403-9. (Pubitemid 46198356)
89. Torjman MC, Jahn L, Joseph JI, Crothall K. Accuracy of the hemocue portable glucose analyzer in a large nonhomogeneous population. Diabetes Technol Ther. 2001;3(4):591-600. (Pubitemid 34202917)
90. Slater-MacLean L, Cembrowski G, Chin D, Shalapay C, Binette T, Hegadoren K, Newburn-Cook C. Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther. 2008;10(3):169-77. (Pubitemid 351677597)
91. Karon BS, Griesmann L, Scott R, Bryant SC, Dubois JA, Shirey TL, Presti S, Santrach PJ. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol Ther. 2008;10(2):111-20. (Pubitemid 351230287)
92. Karon BS, Gandhi GY, Nuttall GA, Bryant SC, Schaff HV, McMahon MM, Santrach PJ. Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol. 2007;127(6):919-26.
93. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47(2):209-14. (Pubitemid 32142918)
94. Mahoney JJ, Ellison JM. Assessing glucose monitor performance - a standardized approach. Diabetes Technol Ther. 2007;9(6):545-52. (Pubitemid 350158796)
95. Nayak PP, Morris K, Lang H, Laker S, Stickley J, Davies P, Barrett T, Gao F, Gough S, Narendran P. Lack of agreement between arterial and central venous blood glucose measurement in critically ill children. Intensive Care Med. 2009;35(4):762-3.
96. Flood J, Joseph J, Kim L, McNulty S, Chervoneva I. Glucose levels in blood simultaneously sampled from the radial artery, vena cava, and fingertip. Anesthesiology. 2007;107:A1123.
97. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
98. Mraovic B. Analysis: continuous glucose monitoring during intensive insulin therapy. J Diabetes Sci Technol. 2009;3(4):960-3.
99. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461-7. (Pubitemid 38174072)
100. Ryan M, Saverese V, Hipszer B, Dizdarevic I, Joseph M, Shively N, Joseph JI. Continuous glucose monitor (CGM) shows potential for early hypoglycemia detection in hospitalized patients. Diabetes Technol Ther. In press 2009.
101. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773-8. (Pubitemid 30128815)
102. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med. 1995;98(1):75-84.
103. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067-72. (Pubitemid 35192812)
104. Yu WK, Li WQ, Li N, Li JS. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol. 2003;9(8):1824-7. (Pubitemid 37038139)
105. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33(7):1624-33. (Pubitemid 40980623)
106. Lukins MB, Manninen PH. Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth Analg. 2005;100(4):1129-33. (Pubitemid 40404222)
107. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041-7. (Pubitemid 37430587)
108. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007-21. (Pubitemid 36644877)
109. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67(2):352-60; discussion 360-2.
110. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233-43. (Pubitemid 351650609)
111. Preiser JC. Restoring normoglycaemia: not so harmless. Crit Care. 2008;12(1):116.
112. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006;10(1):R19.
113. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med. 2006;23(1):1-12.
114. Plank LD, Hill GL. Energy balance in critical illness. Proc Nutr Soc. 2003;62(2):545-52. (Pubitemid 36841630)
115. De Beaux, Chapman M, Fraser R, Finnis M, De Keulenaer B, Liberalli D, Satanek M. Enteral nutrition in the critically ill: a prospective survey in an Australian intensive care unit. Anaesth Intensive Care. 2001;29(6):619-22. (Pubitemid 33138619)
116. Heyland DK, MacDonald S, Keefe L, Drover JW. Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA. 1998;280(23):2013-9.
117. McMahon MM, Miles JM. Glycemic control and nutrition in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2006;9(2):120-3. (Pubitemid 44090035)
118. Hipszer B, Joseph J, Kam M. Pharmacokinetics of intravenous insulin delivery in humans with type 1 diabetes. Diabetes Technol Ther. 2005;7(1):83-93. (Pubitemid 40354578)
119. Watson BG, Elliott MJ, Pay DA, Williamson M. Diabetes mellitus and open heart surgery. A simple, practical closed-loop insulin infusion system for blood glucose control. Anaesthesia. 1986;41(3):250-7. (Pubitemid 16162652)
120. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31(5):934-9.
121. Renard E, Costalat G, Chevassus H, Bringer J. Closed loop insulin delivery using implanted insulin pumps and sensors in type 1 diabetic patients. Diabetes Res Clin Pract. 2006 12;74 Suppl 2:S173-7. (Pubitemid 44917761)